Rituximab as a first-line treatment in pediatric neuromyelitis optica spectrum disorder

Neurol Sci. 2015 Dec;36(12):2301-2. doi: 10.1007/s10072-015-2368-x. Epub 2015 Aug 21.

¹ Unit of Child Neuropsychiatry, Catholic University, Rome, Italy.
² Department of Geriatrics, Neurosciences and Orthopedics, Institute of Neurology, Catholic University, Largo A. Gemelli 8, 00168, Rome, Italy. viviana.nociti@rm.unicatt.it.
³ Don C. Gnocchi Foundation Onlus, Milan, Italy. viviana.nociti@rm.unicatt.it.
⁴ Department of Geriatrics, Neurosciences and Orthopedics, Institute of Neurology, Catholic University, Largo A. Gemelli 8, 00168, Rome, Italy.

No abstract available

Keywords: Aquaporin-4; First-line therapy; Pediatric NMOSD; Rituximab.

Publication types